Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immobilized heparin refers to heparin that is chemically attached to a surface or media, functioning to adsorb and remove pathogens—mainly bacteria—by inhibiting their adhesion to biological or synthetic surfaces[1][2][3]. This anti-adhesive barrier mechanism is used experimentally to prevent infections in mucosal tissues (such as the bladder) or to purify blood by selectively trapping bacteria on heparin-functionalized materials[1][2][3]. Heparin’s action in this context is independent of its anticoagulant properties and is attributed to its mucopolysaccharide structure, which interferes with microbial adhesion[1][2].
Physical adsorption of pathogens to immobilized heparin due to its anti-adhesive properties and affinity for microbial surface structures
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogen adsorption via immobilized heparin.